Most cited papers from Cerus (United States)

Cerus (United States)

What are the most cited papers from Cerus (United States)?

The most cited paper from Cerus (United States) is "An update on Zika virus infection" (David Baud, Duane J. Gubler, Bruno Schaub et al., 2017), with 657 citations. Next come "Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes" (447) and "Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity" (396).

Published TypeFieldAccessCitations

Showing 50 of 57 papers. Every paper with more than 65 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	An update on Zika virus infection David Baud, Duane J. Gubler, Bruno Schaub et al. · The Lancet Open access	22 Jun 2017	657
2	Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes Victoria Auerbuch, Dirk G. Brockstedt, Nicole Meyer-Morse et al. · The Journal of Experimental Medicine Open access	9 Aug 2004	447
3	Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity Camie W. Y. Chan, Emily B. Crafton, Hong-Ni Fan et al. · Nature Medicine	29 Jan 2006	396
4	A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction Dung Thi Le et al. · Clinical Cancer Research Open access	6 Dec 2011	372
5	Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long‐wavelength ultraviolet light Liuyang C. Lin et al. · Transfusion	Apr 1997	342
6	Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial DJ van Rhenen · Blood Open access	27 Nov 2002	313
7	Listeria -based cancer vaccines that segregate immunogenicity from toxicity Dirk G. Brockstedt, Martin A Giedlin, Meredith L.L. Leong et al. · Proceedings of the National Academy of Sciences Open access	13 Sep 2004	302
8	Identification of novel genomic islands coding for antigenic pilus‐like structures in Streptococcus agalactiae Roberto Rosini, C. Daniela Rinaudo, Marco Soriani et al. · Molecular Microbiology Open access	Jun 2006	245
9	High-Resolution Single Particle Zeta Potential Characterisation of Biological Nanoparticles using Tunable Resistive Pulse Sensing Robert Vogel, Anoop K. Pal, Siddharth Jambhrunkar et al. · Scientific Reports Open access	6 Dec 2017	219
10	Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray Rafael Ramiro de Assis et al. · Nature Communications Open access	4 Jan 2021	201
11	Diels–Alder Reactions of 1-Azadienes Mohammad Behforouz, Mohammad Ahmadian · Tetrahedron	Jul 2000	195
12	Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells Monica V. Goldberg, Charles H. Maris, Edward L. Hipkiss et al. · Blood Open access	29 Mar 2007	184
13	Human Immune Response to Recombinant Human Proteins Seth Porter · Journal of Pharmaceutical Sciences	2001	175
14	Photochemical treatment of platelet concentrates with amotosalen and long‐wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria Lily Lin, R. Dikeman, Barbara J. Molini et al. · Transfusion	22 Sep 2004	173
15	Inactivation of Leukocytes in Platelet Concentrates by Photochemical Treatment With Psoralen Plus UVA Joshua A. Grass, Derek J. Hei, Ken Metchette et al. · Blood Open access	15 Mar 1998	173
16	Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long‐wavelength ultraviolet light Lily Lin, Carl Veith Hanson, Harvey J. Alter et al. · Transfusion Open access	22 Mar 2005	171
17	Photochemical treatment of plasma with amotosalen and long‐wavelength ultraviolet light inactivates pathogens while retaining coagulation function Yasmin Singh, Lynette S. W. Sawyer, Linda Pinkoski et al. · Transfusion Open access	26 Jun 2006	165
18	Bacterial Detection of Platelets: Current Problems and Possible Resolutions M.A. Blajchman, Erik A.M. Beckers, Ebbe Dickmeiss et al. · Transfusion Medicine Reviews	Oct 2005	162
19	Zika virus in French Polynesia 2013–14: anatomy of a completed outbreak Didier Musso, Hervé Bossin, H Mallet et al. · The Lancet Infectious Diseases	15 Nov 2017	159
20	Pathogen Inactivation of Platelet and Plasma Blood Components for Transfusion Using the INTERCEPT Blood SystemTM Johannes Irsch, Lily Lin · Transfusion Medicine and Hemotherapy Open access	2011	158
21	Prevention of Transfusion-Associated Graft-Versus-Host Disease by Photochemical Treatment Joshua A. Grass, Tamim Wafa, Aaron Reames et al. · Blood	May 1999	151
22	Inactivation of Z ika virus in plasma with amotosalen and ultraviolet A illumination Maïté Aubry, Vaea Richard, Jennifer Greif Green et al. · Transfusion Open access	18 Aug 2015	143
23	Associations among Screen Time and Unhealthy Behaviors, Academic Performance, and Well-Being in Chinese Adolescents Hanyi Yan, Rui Zhang, Theresa M. Oniffrey et al. · International Journal of Environmental Research and Public Health Open access	4 Jun 2017	141
24	Killed but metabolically active microbes: a new vaccine paradigm for eliciting effector T-cell responses and protective immunity Dirk G. Brockstedt, Keith S. Bahjat, Martin A Giedlin et al. · Nature Medicine	24 Jul 2005	136
25	Protecting the Blood Supply From Emerging Pathogens: The Role of Pathogen Inactivation Jean Pierre Allain, Celso Bianco, Morris A. Blajchman et al. · Transfusion Medicine Reviews Open access	Apr 2005	136
26	Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution Kathryn B. Davis, Sherrill J. Slichter, Laurence Corash · Transfusion	Jun 1999	133
27	Fundamentals of the psoralen-based Helinx™ technology for inactivation of infectious pathogens and leukocytes in platelets and plasma S. Wollowitz · Seminars in Hematology	Oct 2001	124
28	Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial Edward L. Snyder, Jeffrey McCullough, Sherrill J. Slichter et al. · Transfusion	10 Oct 2005	122
29	Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set Karin Janetzko, Jean‐Pierre Cazenave, Harald Klüter et al. · Transfusion	22 Jul 2005	119
30	A multi‐centre study of therapeutic efficacy and safety of platelet components treated with amotosalen and ultraviolet A pathogen inactivation stored for 6 or 7 d prior to transfusion Miquel Lozano, Folke Knutson, R. Tardivel et al. · British Journal of Haematology Open access	21 Mar 2011	114
31	Hybrid Intrusion Detection System for Edge-Based IIoT Relying on Machine-Learning-Aided Detection Haipeng Yao, Pengcheng Gao, Peiying Zhang et al. · IEEE Network	Sep 2019	113
32	Transfusion of platelet components prepared with photochemical pathogen inactivation treatment during a Chikungunya virus epidemic in Ile de La Réunion P. Rasonglès, Marie France Angelini‐Tibert, Philip L. Simon et al. · Transfusion	27 Feb 2009	113
33	An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment J.C. Osselaer et al. · Vox Sanguinis Open access	31 Jan 2008	105
34	Functional Characteristics of S-59 Photochemically Treated Platelet Concentrates Derived from Buffy Coats D.J. van Rhenen, J. Vermeij, V. Mayaudon et al. · Vox Sanguinis Open access	2000	97
35	Recovery and life span of 111 indium‐radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S‐59) and ultraviolet A light Edward L. Snyder, Thomas J. Raife, Lily Lin et al. · Transfusion	Dec 2004	97
36	A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment Jean Claude Osselaer, Nathalie Messe, Tor Audun Hervig et al. · Transfusion	13 Mar 2008	97
37	Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway Edith M. Janssen, Koichi Tabeta, Michael J. Barnes et al. · Immunity Open access	Jun 2006	92
38	NTP‐CERHR expert panel report on the developmental toxicity of soy infant formula Gail McCarver, Jatinder J. S. Bhatia, Christina Chambers et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology	21 Sep 2011	90
39	Photochemical Inactivation of Bacteria and HIV in Buffy‐Coat‐Derived Platelet Concentrates under Conditions That Preserve in vitro Platelet Function Folke Knutson, Ryan Alfonso, Kent W. Dupuis et al. · Vox Sanguinis	Jun 2000	89
40	Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use Jean Claude Osselaer, Chantal Doyen, Laurence Defoin et al. · Transfusion	31 Mar 2009	87
41	Therapeutic efficacy and safety of red blood cells treated with a chemical process (S‐303) for pathogen inactivation: a Phase III clinical trial in cardiac surgery patients Richard J. Benjamin, Jeffrey McCullough, Paul D. Mintz et al. · Transfusion	26 Oct 2005	83
42	Listeria monocytogenes as a Vaccine Vector: Virulence Attenuation or Existing Antivector Immunity Does Not Diminish Therapeutic Efficacy Holly J. Starks, Kevin W. Bruhn, Hao Shen et al. · The Journal of Immunology	Jul 2004	82
43	Resuscitative Strategies to Modulate the Endotheliopathy of Trauma: From Cell to Patient Feng Wu, Amanda M. Chipman, Shibani Pati et al. · Shock Open access	14 May 2019	81
44	A prospective, active haemovigilance study with combined cohort analysis of 19 175 transfusions of platelet components prepared with amotosalen– UVA photochemical treatment Folke Knutson et al. · Vox Sanguinis Open access	15 May 2015	79
45	Trypanosoma cruziInactivation in Human Platelet Concentrates and Plasma by a Psoralen (Amotosalen HCl) and Long-Wavelength UV Wesley C. Van Voorhis, Lynn K. Barrett, Richard T. Eastman et al. · Antimicrobial Agents and Chemotherapy Open access	23 Jan 2003	78
46	Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3‐year period Jean‐Pierre Cazenave, Hervé Isola, Chantal Waller et al. · Transfusion	16 Sep 2010	78
47	Pharmacokinetic and toxicology assessment of INTERCEPT (S-59 and UVA treated) platelets Vic Ciaravino, Tim McCullough, A.D. Dayan · Human & Experimental Toxicology	Oct 2001	77
48	Pharmacokinetic study of FFP photochemically treated with amotosalen (S‐59) and UV light compared to FFP in healthy volunteers anticoagulated with warfarin Julie Hambleton, David S. Wages, Lucian Radu‐Radulescu et al. · Transfusion	Oct 2002	74
49	Hemovigilance monitoring of platelet septic reactions with effective bacterial protection systems Richard J. Benjamin, Thomas M. Braschler, Tina Weingand et al. · Transfusion Open access	24 Aug 2017	73
50	Quantitative Analysis of DNA Interstrand Cross-Links and Monoadducts Formed in Human Cells Induced by Psoralens and UVA Irradiation Congfang Lai, Huachuan Cao, John E. Hearst et al. · Analytical Chemistry Open access	24 Oct 2008	70

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.